Fresenius Medical Care AG & Co. KGaA Capital Reinvestment Ratio
Fresenius Medical Care AG & Co. KGaA capital reinvestment ratio. Fresenius Medical Care AG & Co. KGaA (FMEA) has a Capital Reinvestment Ratio of 0.84x as of March 2026, meaning it reinvests 1% of its operating cash flow (€226.89 Million) in capital expenditures (€190.07 Million). See free cash flow generation of Fresenius Medical Care AG & Co. KGaA to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Fresenius Medical Care AG & Co. KGaA (2016–2025)
Capital reinvestment ratio of Fresenius Medical Care AG & Co. KGaA from 2016 to 2025. This chart tracks Fresenius Medical Care AG & Co. KGaA's Capital Reinvestment Ratio across 10 annual periods. See Fresenius Medical Care AG & Co. KGaA (FMEA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Fresenius Medical Care AG & Co. KGaA Capital Reinvestment Ratio by Year (2016–2025)
Fresenius Medical Care AG & Co. KGaA capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see FMEA cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | €2.68 Billion | €915.37 Million | ▲ +16.5% |
| 2024 | 0.29x | €2.39 Billion | €699.36 Million | ▲ +12.5% |
| 2023 | 0.26x | €2.63 Billion | €684.60 Million | ▼ -22.0% |
| 2022 | 0.33x | €2.17 Billion | €723.99 Million | ▼ -2.7% |
| 2021 | 0.34x | €2.49 Billion | €854.36 Million | ▲ +38.1% |
| 2020 | 0.25x | €4.23 Billion | €1.05 Billion | ▼ -43.3% |
| 2019 | 0.44x | €2.57 Billion | €1.12 Billion | ▼ -14.5% |
| 2018 | 0.51x | €2.06 Billion | €1.06 Billion | ▲ +19.0% |
| 2017 | 0.43x | €2.19 Billion | €944.46 Million | ▼ -15.0% |
| 2016 | 0.51x | €1.93 Billion | €979.36 Million | — |